Detalles de la búsqueda
1.
Characterization and comparison of innate and adaptive immune responses at vaccine sites in melanoma vaccine clinical trials.
Cancer Immunol Immunother;
70(8): 2151-2164, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33454795
2.
Patterns of immune-cell infiltration in murine models of melanoma: roles of antigen and tissue site in creating inflamed tumors.
Cancer Immunol Immunother;
68(7): 1121-1132, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31134297
3.
Heterogeneity of CD8+ tumor-infiltrating lymphocytes in non-small-cell lung cancer: impact on patient prognostic assessments and comparison of quantification by different sampling strategies.
Cancer Immunol Immunother;
66(1): 33-43, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27770170
4.
A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites.
Cancer Immunol Immunother;
65(1): 25-36, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26581199
5.
Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases.
Cancer Immunol Immunother;
65(10): 1189-99, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27522581
6.
Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases.
Cancer Immunol Immunother;
65(10): 1201-12, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27522582
7.
TLR2/6 agonists and interferon-gamma induce human melanoma cells to produce CXCL10.
Int J Cancer;
137(6): 1386-96, 2015 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25765738
8.
A case of spontaneous systemic immunity to melanoma associated with cure after amputation for extensive regional recurrence.
Cancer Immunol Immunother;
62(8): 1327-34, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23666534
9.
VEGFR-2 expression in human melanoma: revised assessment.
Int J Cancer;
129(12): 2807-15, 2011 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21544800
10.
Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist.
J Immunother Cancer;
9(5)2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34035112
11.
Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund's adjuvant, cyclophosphamide, and polyICLC (Mel63).
J Immunother Cancer;
9(1)2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33479025
12.
Dynamic changes in cellular infiltrates with repeated cutaneous vaccination: a histologic and immunophenotypic analysis.
J Transl Med;
8: 79, 2010 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20727190
13.
A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund's adjuvant in melanoma patients.
J Immunother Cancer;
7(1): 163, 2019 06 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31248461
14.
The use of gamma-irradiation and ultraviolet-irradiation in the preparation of human melanoma cells for use in autologous whole-cell vaccines.
BMC Cancer;
8: 360, 2008 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-19055839
15.
PD-L1, PD-L2 and PD-1 expression in metastatic melanoma: Correlation with tumor-infiltrating immune cells and clinical outcome.
Oncoimmunology;
5(11): e1235107, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27999753
16.
Human melanomas and ovarian cancers overexpressing mechanical barrier molecule genes lack immune signatures and have increased patient mortality risk.
Oncoimmunology;
5(12): e1240857, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-28123876
17.
Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrate.
Oncoimmunology;
5(6): e1160193, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27471635
18.
Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed schedule.
J Clin Oncol;
22(22): 4474-85, 2004 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15542798
19.
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells.
J Clin Oncol;
21(21): 4016-26, 2003 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14581425
20.
MHC-restricted phosphopeptides from insulin receptor substrate-2 and CDC25b offer broad-based immunotherapeutic agents for cancer.
Cancer Res;
74(23): 6784-95, 2014 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25297629